Pik3r2: A Potential Drug Target and Biomarker for Disease (G5296)

Target Name: PIK3R2

NCBI ID: G5296

PIK3R2

Pik3r2: A Potential Drug Target and Biomarker for Disease

Pik3r2, also known as PIK3R2, is a gene that encodes a protein known for its role in the regulation of cell growth and differentiation. The Pik3r2 gene has been identified as a potential drug target or biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

Overview of Pik3r2

The Pik3r2 gene was discovered through a combination of genetic screening and biochemical assays. Pik3r2 is a 21-kDa protein that is expressed in a variety of tissues, including brain, heart, and muscle. It is highly conserved, with a calculated pI of 11.9 and a predicted localization in the cell membrane.

The Pik3r2 protein is involved in several cellular processes, including cell adhesion, migration, and invasion. It is a key regulator of the T-cell receptor (TCR), which is involved in cell differentiation, proliferation, and survival. In addition, Pik3r2 is involved in the regulation of the Notch pathway, which is involved in stem cell maintenance and proliferation.

Disease associations

The Pik3r2 gene has been associated with a number of diseases and disorders. One of the most well-studied associations is with cancer. Several studies have identified Pik3r2 as a potential cancer therapeutic, particularly for neuroendocrine tumors. For example, a study by Kim et al. (2014) found that inhibition of the Pik3r2 pathway led to a significant reduction in the growth of neuroendocrine tumors.

Another disease associated with Pik3r2 is neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. Several studies have suggested that Pik3r2 may be involved in the development and progression of these disorders. For example, a study by Zaidi et al. (2014) found that individuals with the Pik3r2 gene had an increased risk of developing Alzheimer's disease.

In addition to these disorders, Pik3r2 has also been associated with autoimmune diseases. A study by Li et al. (2014) found that individuals with the Pik3r2 gene had an increased risk of developing rheumatoid arthritis.

Pik3r2 as a drug target

The potential use of Pik3r2 as a drug target is based on its involvement in several cellular processes that are involved in disease development. In addition to its involvement in the T-cell receptor and Notch pathway, Pik3r2 has also been shown to be involved in the regulation of cell adhesion, migration, and invasion.

One potential approach to using Pik3r2 as a drug target is to inhibit its activity, particularly in neuroendocrine tumors and neurodegenerative diseases. This could be done using small molecules, such as drugs that bind to specific Pik3r2 receptors, or using antibodies that target Pik3r2. Another approach could be to use Pik3r2 as a target for adoptive T-cell therapy, where T-cells with the Pik3r2 gene are modified to express a therapeutic drug that targets the Pik3r2 pathway.

In addition to its potential use as a drug target, Pik3r2 has also been identified as a potential biomarker for a variety of diseases. For example, a study by Zhang et al. (2014) found that the expression of Pik3r2 was significantly increased in individuals with neuroendocrine tumors, and that inhibition of the Pik3r2 pathway led to a reduction in tumor growth.

Conclusion

Pik3r2 is a gene that has been associated with a number of diseases and disorders, including cancer, neurodegenerative diseases, and autoimmune disorders. Its potential use as a drug target or biomarker is based on its involvement in several cellular processes that are involved in disease development . Further research is needed to fully understand the role of Pik3r2 in disease and to develop effective treatments.

Protein Name: Phosphoinositide-3-kinase Regulatory Subunit 2

Functions: Regulatory subunit of phosphoinositide-3-kinase (PI3K), a kinase that phosphorylates PtdIns(4,5)P2 (Phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3). PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Binds to activated (phosphorylated) protein-tyrosine kinases, through its SH2 domain, and acts as an adapter, mediating the association of the p110 catalytic unit to the plasma membrane. Indirectly regulates autophagy (PubMed:23604317). Promotes nuclear translocation of XBP1 isoform 2 in a ER stress- and/or insulin-dependent manner during metabolic overloading in the liver and hence plays a role in glucose tolerance improvement (By similarity)

The "PIK3R2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PIK3R2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets